Pacific Biosciences Of California Current Ratio 2010-2024 | PACB
Pacific Biosciences Of California current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Pacific Biosciences Of California Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-09-30 | $0.58B | $0.06B | 9.74 |
| 2024-06-30 | $0.63B | $0.08B | 8.01 |
| 2024-03-31 | $0.68B | $0.07B | 9.28 |
| 2023-12-31 | $0.74B | $0.10B | 7.81 |
| 2023-09-30 | $0.88B | $0.18B | 4.80 |
| 2023-06-30 | $0.94B | $0.27B | 3.45 |
| 2023-03-31 | $0.98B | $0.27B | 3.69 |
| 2022-12-31 | $0.85B | $0.26B | 3.24 |
| 2022-09-30 | $0.91B | $0.08B | 11.19 |
| 2022-06-30 | $0.97B | $0.08B | 11.50 |
| 2022-03-31 | $1.03B | $0.06B | 16.87 |
| 2021-12-31 | $1.10B | $0.07B | 15.36 |
| 2021-09-30 | $1.13B | $0.06B | 20.32 |
| 2021-06-30 | $1.19B | $0.05B | 26.17 |
| 2021-03-31 | $1.20B | $0.03B | 35.45 |
| 2020-12-31 | $0.36B | $0.04B | 9.24 |
| 2020-09-30 | $0.24B | $0.13B | 1.84 |
| 2020-06-30 | $0.15B | $0.13B | 1.15 |
| 2020-03-31 | $0.17B | $0.13B | 1.29 |
| 2019-12-31 | $0.08B | $0.05B | 1.65 |
| 2019-09-30 | $0.08B | $0.05B | 1.52 |
| 2019-06-30 | $0.10B | $0.05B | 2.00 |
| 2019-03-31 | $0.11B | $0.05B | 2.50 |
| 2018-12-31 | $0.13B | $0.03B | 4.90 |
| 2018-09-30 | $0.14B | $0.02B | 6.65 |
| 2018-06-30 | $0.10B | $0.02B | 4.33 |
| 2018-03-31 | $0.12B | $0.03B | 4.64 |
| 2017-12-31 | $0.10B | $0.03B | 3.55 |
| 2017-09-30 | $0.11B | $0.03B | 3.75 |
| 2017-06-30 | $0.13B | $0.04B | 3.72 |
| 2017-03-31 | $0.09B | $0.04B | 2.49 |
| 2016-12-31 | $0.11B | $0.03B | 3.23 |
| 2016-09-30 | $0.12B | $0.03B | 3.81 |
| 2016-06-30 | $0.14B | $0.03B | 4.08 |
| 2016-03-31 | $0.12B | $0.03B | 3.72 |
| 2015-12-31 | $0.11B | $0.04B | 2.90 |
| 2015-09-30 | $0.09B | $0.04B | 2.22 |
| 2015-06-30 | $0.09B | $0.04B | 2.31 |
| 2015-03-31 | $0.10B | $0.04B | 2.59 |
| 2014-12-31 | $0.12B | $0.03B | 3.74 |
| 2014-09-30 | $0.11B | $0.03B | 3.92 |
| 2014-06-30 | $0.12B | $0.03B | 4.29 |
| 2014-03-31 | $0.13B | $0.02B | 5.87 |
| 2013-12-31 | $0.13B | $0.02B | 5.61 |
| 2013-09-30 | $0.14B | $0.02B | 6.31 |
| 2013-06-30 | $0.12B | $0.02B | 8.09 |
| 2013-03-31 | $0.13B | $0.01B | 9.31 |
| 2012-12-31 | $0.12B | $0.02B | 7.80 |
| 2012-09-30 | $0.13B | $0.01B | 9.71 |
| 2012-06-30 | $0.15B | $0.02B | 10.23 |
| 2012-03-31 | $0.18B | $0.02B | 8.93 |
| 2011-12-31 | $0.20B | $0.02B | 10.30 |
| 2011-09-30 | $0.22B | $0.02B | 10.42 |
| 2011-06-30 | $0.25B | $0.02B | 11.40 |
| 2011-03-31 | $0.26B | $0.02B | 10.95 |
| 2010-12-31 | $0.29B | $0.02B | 14.07 |
| 2010-09-30 | $0.12B | $0.02B | 5.12 |
| 2010-06-30 | $0.00B | 0.00 | |
| 2010-03-31 | $0.00B | 0.00 | |
| 2009-12-31 | $0.00B | 0.00 | |
| 2009-09-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.540B | $0.201B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $200.449B | 24.45 |
| Intuitive Surgical (ISRG) | United States | $186.791B | 97.66 |
| Edwards Lifesciences (EW) | United States | $44.123B | 28.02 |
| Alcon (ALC) | Switzerland | $41.807B | 27.97 |
| IQVIA Holdings (IQV) | United States | $35.805B | 19.73 |
| IDEXX Laboratories (IDXX) | United States | $33.758B | 39.76 |
| DexCom (DXCM) | United States | $31.263B | 47.08 |
| Waters (WAT) | United States | $21.860B | 32.32 |
| STERIS (STE) | Ireland | $20.481B | 23.58 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.736B | 0.00 |
| Hologic (HOLX) | United States | $16.260B | 17.56 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.386B | 13.74 |
| Sysmex ADR (SSMXY) | Japan | $11.751B | 0.00 |
| Globus Medical (GMED) | United States | $11.252B | 28.49 |
| Penumbra (PEN) | United States | $9.308B | 91.18 |
| Masimo (MASI) | United States | $9.076B | 43.92 |
| Glaukos (GKOS) | United States | $8.319B | 0.00 |
| Teleflex (TFX) | United States | $8.274B | 13.20 |
| Integer Holdings (ITGR) | United States | $4.484B | 25.41 |
| PROCEPT BioRobotics (PRCT) | United States | $4.236B | 0.00 |
| Inari Medical (NARI) | United States | $3.246B | 0.00 |
| Veracyte (VCYT) | United States | $3.169B | 95.09 |
| LivaNova (LIVN) | United Kingdom | $2.584B | 14.92 |
| Nihon Kohden (NHNKY) | Japan | $2.392B | 18.17 |
| Tandem Diabetes Care (TNDM) | United States | $2.358B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.084B | 18.74 |
| TransMedics (TMDX) | United States | $2.071B | 65.64 |
| Integra LifeSciences Holdings (IART) | United States | $1.682B | 8.79 |
| RxSight (RXST) | United States | $1.357B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.326B | 0.00 |
| Artivion (AORT) | United States | $1.194B | 79.11 |
| Pulse Biosciences (PLSE) | United States | $1.106B | 0.00 |
| OPKO Health (OPK) | United States | $1.051B | 0.00 |
| Paragon 28 (FNA) | United States | $0.840B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.739B | 12.56 |
| Mesa Laboratories (MLAB) | United States | $0.717B | 16.91 |
| IRadimed (IRMD) | United States | $0.693B | 37.43 |
| AxoGen (AXGN) | United States | $0.688B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.666B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.573B | 30.14 |
| SiBone (SIBN) | United States | $0.556B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.542B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.434B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.429B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.408B | 22.08 |
| AngioDynamics (ANGO) | United States | $0.361B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.352B | 0.00 |
| NeuroPace (NPCE) | United States | $0.344B | 0.00 |
| CVRx (CVRX) | United States | $0.294B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.217B | 0.00 |
| Inogen (INGN) | United States | $0.202B | 0.00 |
| Accuray (ARAY) | United States | $0.186B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.184B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.181B | 0.00 |
| Nevro (NVRO) | United States | $0.142B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.121B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.116B | 12.46 |
| Spectral Diagnostics (EDTXF) | Canada | $0.091B | 0.00 |
| LENSAR (LNSR) | United States | $0.089B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.081B | 0.00 |
| InspireMD (NSPR) | Israel | $0.078B | 0.00 |
| 908 Devices (MASS) | United States | $0.072B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.071B | 0.00 |
| Hyperfine (HYPR) | United States | $0.065B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.064B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.061B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.046B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.044B | 0.00 |
| Neuronetics (STIM) | United States | $0.042B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| NexGel (NXGL) | United States | $0.032B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.023B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.012B | 0.00 | |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.009B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.007B | 0.00 |
| PAVmed (PAVM) | United States | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.006B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |